Literature DB >> 8887737

The synthesis and some pharmacological actions of the enantiomers of the K(+)-channel blocker cetiedil.

C J Roxburgh1, C R Ganellin, M A Shiner, D C Benton, P M Dunn, Y Ayalew, D H Jenkinson.   

Abstract

Cetiedil ((+/-)-2-cyclohexyl-2-(3-thienyl)ethanoic acid 2-(hexahydro-1 H-azepin-1-yl) ethyl ester) possesses anti-sickling and analgesic, antispasmodic, local anaesthetic and vasodilator activities. A total synthesis and circular dichroism spectra of the enantiomers of cetiedil is described, together with a comparison of their effectiveness as blockers of the Ca(2+)-activated K+ permeability of rabbit erythrocytes; the contractile response of intestinal smooth muscle to acetylcholine; the Ca(2+)-dependent contraction of depolarized intestinal muscle; and the cell volume-sensitive K+ permeability (Kvol) of liver cells. The enantiomers did not differ substantially in their ability to block the Ca(2+)-activated K+ permeability of rabbit red cells or in their effectiveness as blockers of the contractile response of depolarized smooth muscle to externally applied Ca2+. There was a clear difference in the muscarinic blocking activity of the enantiomers, as assessed by inhibition of the contractile response of intestinal smooth muscle to acetylcholine; (+)-cetiedil was 7.7 +/- 0.2 (s.d.) times more active than the (-) from. The enantiomers also differed in their potency as blockers of the increase in membrane conductance which occurs when liver cells swell. The concentration of (+)-cetiedil needed to reduce the conductance increase by 50% was 2.04 +/- 0.54 (s.d.) microM; (-)-cetiedil was 2.6 +/- 0.8 (s.d.) times less active (IC50 of 5.2 +/- 1.2 microM). Differences in the biological actions of the enantiomers of cetiedil indicate that a more extensive study could be rewarding in relation to the use of the enantiomers both in therapeutics and in the study of K+ channels.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8887737     DOI: 10.1111/j.2042-7158.1996.tb03986.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  2 in total

1.  Differences in the actions of some blockers of the calcium-activated potassium permeability in mammalian red cells.

Authors:  D C Benton; C J Roxburgh; C R Ganellin; M A Shiner; D H Jenkinson
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

2.  Palladium-catalyzed asymmetric allylic alkylation of 2-acylimidazoles as ester enolate equivalents.

Authors:  Barry M Trost; Konrad Lehr; David J Michaelis; Jiayi Xu; Andreas K Buckl
Journal:  J Am Chem Soc       Date:  2010-07-07       Impact factor: 15.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.